0 items USD 0.00Search
- Did you mean
- veinsight ritual drug insight200
Your search for "delveinsight rituxan drug insights2014" gave back 41009 results.
Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer. Publisher...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer. According...
Catalog:
GIR
January 2023
Price: USD 3,480.00
The “Biologic Drugs Industry Forecast” looks at past sales and reviews total world Biologic Drugs sales in 2022, providing a comprehensive analysis...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several...
Catalog:
LPI
February 2023
Price: USD 3,660.00
RITUXAN is a type of antibody therapy that can be used alone or with chemotherapy. Publisher' newest research report, the “Rituxan Industry...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Rituxan (Rituximab) and Biosimilar market size is projected to grow from US$ 4035.3 million in 2022 to US$ 5179.6 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Rituxan (Rituximab) Monoclonal Antibody market size is projected to grow from US$ 4035.3 million in 2022 to US$ 5179.6 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Rituxan market size was valued at US$ 1000.7 million in 2023. With growing demand in downstream market, the Rituxan is forecast to a...
Catalog:
LPI
March 2024
Price: USD 3,660.00
The global Rituxan (Rituximab) and Biosimilar market size is expected to reach $ 5345.4 million by 2029, rising at a market growth of 3.3% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Rituxan (Rituximab) Monoclonal Antibody market size is expected to reach $ 5345.4 million by 2029, rising at a market growth of 3.3% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
RITUXAN is a type of antibody therapy that can be used alone or with chemotherapy. According to our Publisher latest study, the global Rituxan market...
Catalog:
GIR
January 2023
Price: USD 3,480.00
The global Rituxan (Rituximab) and Biosimilar market size was valued at USD 4244.4 million in 2022 and is forecast to a readjusted size of USD 5345.4...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global Rituxan (Rituximab) Monoclonal Antibody market size was valued at USD 4244.4 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer. Publisher...
Catalog:
LPI
February 2023
Price: USD 3,660.00
